Sebastian Schulz

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann, Prerna Arora, Rüdiger Groß et al. · Cell · 2021 · 1K citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch et al. · European Journal of Immunology · 2019 · 993 citations · Full text

Life Sciences, Cell Biology, Immunology +13

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Markus Hoffmann, Nadine Krüger, Sebastian Schulz et al. · Cell · 2021 · 955 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Observational Study Mortality in Treated Primary Aldosteronism

Martín Reincke, Evelyn Fischer, S. Gerum et al. · Hypertension · 2012 · 273 citations · Full text

Medicine, Cardiology, Endocrinology +9

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger et al. · Cell Reports · 2021 · 242 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17